97 related articles for article (PubMed ID: 34542089)
21. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
[TBL] [Abstract][Full Text] [Related]
22. Practice Bulletin No. 157: Cervical Cancer Screening and Prevention.
Obstet Gynecol; 2016 Jan; 127(1):e1-e20. PubMed ID: 26695583
[TBL] [Abstract][Full Text] [Related]
23. ASCCP Practice Guidelines Management Guidelines for the Follow-up of Atypical Squamous Cells of Undetermined Significance (ASCUS).
Cox TJ; Wilkinson EJ; Lonky N; Waxman A; Tosh R; Tedeschi C
J Low Genit Tract Dis; 2000 Apr; 4(2):99-105. PubMed ID: 25950896
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of Cervical Visual Inspection with Acetic Acid Guide for 4-Quadrant Random Cervical Biopsies by General Practitioners in Women with Abnormal Pap Smears.
Suwansura P; Darojn D
Asian Pac J Cancer Prev; 2017 Aug; 18(8):2063-2066. PubMed ID: 28843222
[TBL] [Abstract][Full Text] [Related]
25. ASCCP Practice Guidelines: The Follow-Up System for Abnormal Cervical Cytological Findings.
Cox JT
J Low Genit Tract Dis; 1997 Jul; 1(3):167-70. PubMed ID: 25951023
[No Abstract] [Full Text] [Related]
26. Updates in Cervical Cytology: The 90-Year-Long Journey from Battle Creek to Today.
Roe CJ; Hanley KZ
Surg Pathol Clin; 2018 Sep; 11(3):589-599. PubMed ID: 30190142
[TBL] [Abstract][Full Text] [Related]
27. Developing guidelines for cervical cancer prevention in the face of diagnostic complexity.
Massad LS
J Natl Compr Canc Netw; 2014 Mar; 12(3):349-53. PubMed ID: 24616540
[TBL] [Abstract][Full Text] [Related]
28. [Investigation of human papillomavirus prevalence in women in Eskişehir, Turkey by Pap smear, hybrid capture 2 test and consensus real-time polymerase chain reaction and typing with pyrosequencing method].
Aslan FG; Us T; Kaşifoğlu N; Özalp SS; Akgün Y; Öge T
Mikrobiyol Bul; 2016 Jan; 50(1):73-85. PubMed ID: 27058331
[TBL] [Abstract][Full Text] [Related]
29. ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice.
Khan MJ; Werner CL; Darragh TM; Guido RS; Mathews C; Moscicki AB; Mitchell MM; Schiffman M; Wentzensen N; Massad LS; Mayeaux EJ; Waxman AG; Conageski C; Einstein MH; Huh WK
J Low Genit Tract Dis; 2017 Oct; 21(4):223-229. PubMed ID: 28953110
[TBL] [Abstract][Full Text] [Related]
30. Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States.
Wentzensen N; Massad LS; Mayeaux EJ; Khan MJ; Waxman AG; Einstein MH; Conageski C; Schiffman MH; Gold MA; Apgar BS; Chelmow D; Choma KK; Darragh TM; Gage JC; Garcia FAR; Guido RS; Jeronimo JA; Liu A; Mathews CA; Mitchell MM; Moscicki AB; Novetsky AP; Papasozomenos T; Perkins RB; Silver MI; Smith KM; Stier EA; Tedeschi CA; Werner CL; Huh WK
J Low Genit Tract Dis; 2017 Oct; 21(4):216-222. PubMed ID: 28953109
[TBL] [Abstract][Full Text] [Related]
31. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.
Wright TC; Schiffman M; Solomon D; Cox JT; Garcia F; Goldie S; Hatch K; Noller KL; Roach N; Runowicz C; Saslow D
Obstet Gynecol; 2004 Feb; 103(2):304-9. PubMed ID: 14754700
[TBL] [Abstract][Full Text] [Related]
32. Atypical squamous cells: update on current concepts.
Nayar R; Tabbara SO
Clin Lab Med; 2003 Sep; 23(3):605-32. PubMed ID: 14560531
[TBL] [Abstract][Full Text] [Related]
33. Liquid-Based Screening Tests Results: HPV, Liquid-Based Cytology, and P16/Ki67 Dual-Staining in Private-Based Opportunistic Cervical Cancer Screening.
Trzeszcz M; Mazurec M; Jach R; Mazurec K; Jach Z; Kotkowska-Szeps I; Kania M; Wantuchowicz M; Prokopyk A; Barcikowski P; Przybylski M; Wach J; Halon A
Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441354
[TBL] [Abstract][Full Text] [Related]
34. ACOG Practice Bulletin Number 131: Screening for cervical cancer.
Committee on Practice Bulletins—Gynecology
Obstet Gynecol; 2012 Nov; 120(5):1222-38. PubMed ID: 23090560
[TBL] [Abstract][Full Text] [Related]
35. ASCCP Colposcopy Standards: Colposcopy Quality Improvement Recommendations for the United States.
Mayeaux EJ; Novetsky AP; Chelmow D; Garcia F; Choma K; Liu AH; Papasozomenos T; Einstein MH; Massad LS; Wentzensen N; Waxman AG; Conageski C; Khan MJ; Huh WK
J Low Genit Tract Dis; 2017 Oct; 21(4):242-248. PubMed ID: 28953113
[TBL] [Abstract][Full Text] [Related]
36. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
[TBL] [Abstract][Full Text] [Related]
37. Are the University Hospitals in Puerto Rico following Current Guidelines for Cervical Cancer Screening?
Méndez K; Rodríguez N; Sánchez I; Lozada Y; Piñero I; Donate D; Romaguera J
P R Health Sci J; 2015 Sep; 34(3):142-7. PubMed ID: 26356738
[TBL] [Abstract][Full Text] [Related]
38. ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.
Fontaine PL; Saslow D; King VJ
Am Fam Physician; 2012 Sep; 86(6):501, 506-7. PubMed ID: 23062041
[No Abstract] [Full Text] [Related]
39. Use of extended HR-HPV Genotyping in improving the Triage Strategy of 2019 ASCCP recommendations in Women with positive HR-HPV diagnosis and Simultaneous LSIL Cytology Results.
Xue H; Gao H; Zheng J; Chen Y; Chen J; Pan D; Dong B; Sun P
J Cancer; 2021; 12(14):4332-4340. PubMed ID: 34093833
[No Abstract] [Full Text] [Related]
40. Follow-up for cervical abnormalities in a managed care plan, 1999-2004.
Benard VB; Berkman ND; Kuo T; Martin CK; Richardson LC
Prev Med; 2010; 50(1-2):81-5. PubMed ID: 19932710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
